News and blogs
358 results found.
Blood cancer UK reacts to £100m investment into regional hubs for clinical trials
We welcome the government’s investment of £100 million in public-private investment to establish 20 new Commercial Research Delivery Centres (CRDCs) across the UK.
12th Dec 2024
Blood Cancer UK named BioIndustry Association's 2025 charity partner of the year
The BIA will support Blood Cancer UK through strategic opportunities and fundraising activities over the next 12 months.
9th Dec 2024
Stem cell transplant research gives hope to those with blood cancer
Blood Cancer UK-funded researchers at the University of Birmingham have identified a key target, CD70, to reduce the likelihood of ‘graft-versus-host disease’ which people with blood cancer can develop after receiving a life-saving stem cell transplant.
27th Nov 2024
How to make the most of the holiday season
People living with blood cancer share their tips about how to make the holiday season as festive as possible, while staying safe and relaxed.
22nd Nov 2024
Top 10 gifts for someone with blood cancer
What would someone with blood cancer like for Christmas? Read out top ten picks for things that might make a difference, whether in hospital or at home.
22nd Nov 2024
New blood cancer drugs in Scotland approved
Regulators in Scotland, has approved two new blood cancer treatments for use on the NHS in Scotland. A CAR-T therapy for diffuse large B-cell lymphoma is one of the treatments.
11th Nov 2024
24 hour clubathon raises funds for friend on the Wirral
Friends from Wallasey, on the Wirral, will host a special 24-hour Clubathon event in support of one of their close-knit community Laura Parker, 35, who has an aggressive leukaemia, a form of blood cancer.
6th Nov 2024
Interferon supplies for people with MPNs (Pegasys)
Find out what Blood Cancer UK is doing to solve the UK shortage of pegylated interferon alfa 2a (Pegasys), and what you can do if you take Pegasys to treat an MPN.
4th Nov 2024
New life-changing myeloma drug given positive recommendation for fourth-line use on the NHS for those ‘exhausting’ options
The drug teclistamab (Tecvayli), has been recommended by NICE to treat myeloma, a form of blood cancer, in England and Wales.
10th Oct 2024
Why at Blood Cancer UK we think the new investment towards improving cancer detection from the government is promising
The government has announced a number of new partnerships backed by public and private sector investment to tackle cancer and other life-threatening diseases with faster diagnoses and better treatments, deploying innovative technologies and approaches.
7th Oct 2024
Dr Jewel Cobb – cancer researcher and champion of equality
Dr Jewel Plummer Cobb was an African American cell biologist and physiologist who contributed to pioneering research into cancer treatment.
27th Sep 2024
A step forward for people with blood cancer
The drug quizartinib is now available for people with this specific form of blood cancer on the NHS in England.
24th Sep 2024
World Cancer Research Day: our new research projects
We are funding eight new research projects we are funding taking our total number of research projects to 87 across the UK.
24th Sep 2024
Mpox (monkeypox) and blood cancer
Find out about mpox, how it spreads, signs and symptoms, cases in the UK, and what it means for people with blood cancer.
10th Sep 2024
Our Blood Cancer Action Plan to tackle blood cancer survival in the UK
Blood Cancer UK releases its comprehensive Action Plan "Taking blood cancer out of the shadows: A plan to increase survival in the UK"
4th Sep 2024
Wales lags behind England in blood cancer survival
Our press release on our Blood Cancer Action Plan reveals how Wales is lagging behind England when it comes to blood cancer survival. Our landmark report is available to download in English and Welsh.
4th Sep 2024
Ellie's blood cancer story
Ellie lived with acute myeloid leukaemia (AML). Her family are encouraging people to donate towards life-saving research.
12th Aug 2024
Take at home tablet approved for blood cancer on NHS England
Zanubrutinib, is now available on the NHS in England for those with a type of blood cancer called marginal zone lymphoma.,
1st Aug 2024
Drug, dasatinib approved for use on the NHS in Scotland
Dasatinib, is now approved for the treatment of adults with a form of leukaemia - Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL) - on the NHS in Scotland.
25th Jul 2024
New class of drug approved for myeloma in England and Wales
The very first bispecific drug for myeloma, elranatamab has been approved for restricted use in England and Wales as a fourth-line treatment.
27th Jun 2024